BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lu K, Shi TS, Shen SY, Shi Y, Gao HL, Wu J, Lu X, Gao X, Ju HX, Wang W, Cao Y, Chen D, Li CJ, Xue B, Jiang Q. Defects in a liver-bone axis contribute to hepatic osteodystrophy disease progression. Cell Metab 2022;34:441-457.e7. [PMID: 35235775 DOI: 10.1016/j.cmet.2022.02.006] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhang Y, Ni X, Wei L, Yu Y, Zhu B, Bai Y, Pei X, Gao F, Guo L, Yong Z, Zhao W. METTL3 alleviates D-gal-induced renal tubular epithelial cellular senescence via promoting miR-181a maturation. Mech Ageing Dev 2023;210:111774. [PMID: 36608773 DOI: 10.1016/j.mad.2022.111774] [Reference Citation Analysis]
2 Gao H, Wu J, Sun Z, Zhang F, Shi T, Lu K, Qian D, Yin Z, Zhao Y, Qin J, Xue B. Influence of lecithin cholesterol acyltransferase alteration during different pathophysiologic conditions: A 45 years bibliometrics analysis. Front Pharmacol 2022;13:1062249. [PMID: 36588724 DOI: 10.3389/fphar.2022.1062249] [Reference Citation Analysis]
3 Li Q, Xu R, Lei K, Yuan Q. Insights into skeletal stem cells. Bone Res 2022;10:61. [PMID: 36261411 DOI: 10.1038/s41413-022-00235-8] [Reference Citation Analysis]
4 Yuan W, Song C. Crosstalk between bone and other organs. Medical Review 2022;0. [DOI: 10.1515/mr-2022-0018] [Reference Citation Analysis]
5 Sonoda S, Murata S, Yamaza H, Yuniartha R, Fujiyoshi J, Yoshimaru K, Matsuura T, Oda Y, Ohga S, Tajiri T, Taguchi T, Yamaza T. Targeting hepatic oxidative stress rescues bone loss in liver fibrosis. Mol Metab 2022;66:101599. [PMID: 36113772 DOI: 10.1016/j.molmet.2022.101599] [Reference Citation Analysis]
6 Baschant U, Altamura S, Steele-Perkins P, Muckenthaler MU, Spasić MV, Hofbauer LC, Steinbicker AU, Rauner M. Iron effects versus metabolic alterations in hereditary hemochromatosis driven bone loss. Trends Endocrinol Metab 2022;33:652-63. [PMID: 35871125 DOI: 10.1016/j.tem.2022.06.004] [Reference Citation Analysis]
7 Gao H, Wu J, Sun ZS, Zhang F, Shi T, Lu K, Qian D, Zhao Y, Qin J, Xue B. Influence of Lecithin cholesterol acyltransferase alteration during different pathophysiologic conditions: a 45 years bibliometrics analysis (Preprint).. [DOI: 10.2196/preprints.42222] [Reference Citation Analysis]
8 Pan J, Zhou L, Zhang C, Xu Q, Sun Y. Targeting protein phosphatases for the treatment of inflammation-related diseases: From signaling to therapy. Signal Transduct Target Ther 2022;7:177. [PMID: 35665742 DOI: 10.1038/s41392-022-01038-3] [Reference Citation Analysis]
9 Zhang X, Ding K, Miao X, Wang J, Hu B, Shen J, Hu X, Xu Y, Yu B, Tu T, Lin A, Chen X, Huang Y. Associations between bone mineral density and chronic obstructive pulmonary disease. J Int Med Res 2022;50:3000605221094644. [PMID: 35579181 DOI: 10.1177/03000605221094644] [Reference Citation Analysis]
10 Zaidi M, Yuen T, Iqbal J. Reverse cholesterol transport and hepatic osteodystrophy. Cell Metab 2022;34:347-9. [PMID: 35235770 DOI: 10.1016/j.cmet.2022.02.007] [Reference Citation Analysis]